Author:
Saunders M P,Hogg M,Carrington B,Sjursen A-M,Allen J,Beech J,Swindell R,Valle J W
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14 (Suppl 2): ii13–ii16
2. Burris H, Kalman L, Bertoli L, Foulke R, Ratner L, Schwartzberg L, Weitberg A, Lokich J (2004) Continuous flat-dose capecitabine plus weekly irinotecan: an alternative first-line treatment for the treatment of metastatic colorectal cancer. Gastrointestinal Cancers Symposium, www.ASCO.org
3. Conti JA, Kemeny NE, Saltz LB, Huang Y, Tong WP, Chou TC, Sun M, Pulliam S, Gonzalez C (1996) Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol 14: 709–715
4. Cunningham D, Pyrhonen S, James RD, Punt CJ, Hickish TF, Heikkila R, Johannesen TB, Starkhammar H, Topham CA, Awad L, Jacques C, Herait P (1998) Randomised trial of irinotecan plus supportive care vs supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352: 1413–1418
5. de Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E, Bedenne L (1997) Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 15: 808–815
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献